Category Archives: Uncategorized

20 Feb

Aimmune’s Peanut Allergy Drug Hits Study Goals, FDA Filing Planned

Peanuts rank among the top foods that spark allergic reactions, prompting schools to ban peanut butter sandwiches and travelers to

20 Feb

Call for proposals for ERC Proof of Concept Grant

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: ERC-2017-PoCPillar: Excellent ScienceOpening Date: Deadline: Tue, 5 Sep 2017 17:00:00 (Brussels local time)Modification Date: Tue, 20 Feb

20 Feb

Under the Microscope We Place Shares of Puma Biotechnology, Inc. (NYSE:PBYI) and Dorman …

Dedicated investors are constantly on the lookout for a bargain when it comes to stock picking. As of late, investors

19 Feb

Call for proposals for ERC Consolidator Grant

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: ERC-2018-COGPillar: Excellent ScienceOpening Date: Deadline: Thu, 15 Feb 2018 17:00:00 (Brussels local time)Modification Date: Mon, 19 Feb

19 Feb

New Infographic: Balancing Need for Innovation with Competition

It is an underreported fact that the time it takes for a generic medicine to come to market has remained

18 Feb

50000 Shares in Puma Biotechnology Inc (PBYI) Acquired by Artal Group SA

Puma Biotechnology logo Artal Group S.A. bought a new position in shares of Puma Biotechnology Inc (NASDAQ:PBYI) during the 4th

17 Feb

FET-Open – Novel ideas for radically new technologies

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-FETOPEN-2016-2017Pillar: Excellent ScienceOpening Date: Deadline: Wed, 11 May 2016 17:00:00 (Brussels local time)Modification Date: Sat, 17 Feb

16 Feb

Gene-Editing: How Do We Move Towards Acceptance

As biotechnology continues to drive advancement in the way we grow and consume food, consumer skepticism around biotechnology remains steady.

16 Feb

LGC Acquires Lucigen, Marking Latest Exit for CEO Ralph Kauten

Chalk up another exit for Ralph Kauten. Kauten, one of Wisconsin’s more successful biotech entrepreneurs, is chairman and CEO of

16 Feb

BUILDING A LOW-CARBON, CLIMATE RESILIENT FUTURE: SECURE, CLEAN AND EFFICIENT ENERGY

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-LC-SC3-2018-2019-2020Pillar: Societal ChallengesPlanned Opening Date: Deadline: Tue, 5 Feb 2019 17:00:00 (Brussels local time)Modification Date: Fri, 16